Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2007 2
2009 1
2013 2
2014 1
2015 1
2016 2
2017 2
2018 8
2019 8
2020 6
2022 1
2023 10
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Ablation of hematopoietic stem cell derived adipocytes reduces tumor burden in syngeneic mouse models of high-grade serous carcinoma.
Woodruff ER, Bailey CA, To F, Manda V, Maltzahn JK, Sullivan TM, Boorgula MP, Recouvreux MS, Vianzon R, Conrad B, Gavin KM, Jordan KR, Klemm DJ, Orsulic S, Bitler BG, Watson ZL. Woodruff ER, et al. Among authors: watson zl. bioRxiv [Preprint]. 2024 Sep 25:2024.09.19.613924. doi: 10.1101/2024.09.19.613924. bioRxiv. 2024. PMID: 39345441 Free PMC article. Preprint.
EHMT1/2 Inhibition Promotes Regression of Therapy-Resistant Ovarian Cancer Tumors in a CD8 T-cell-Dependent Manner.
Nguyen LL, Watson ZL, Ortega R, Woodruff ER, Jordan KR, Iwanaga R, Yamamoto TM, Bailey CA, To F, Lin S, Villagomez FR, Jeong AD, Guntupalli SR, Behbakht K, Gibaja V, Arnoult N, Chuong EB, Bitler BG. Nguyen LL, et al. Among authors: watson zl. Mol Cancer Res. 2024 Dec 3;22(12):1117-1127. doi: 10.1158/1541-7786.MCR-24-0067. Mol Cancer Res. 2024. PMID: 39136655
Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation.
Nguyen LL, Watson ZL, Ortega R, Woodruff ER, Jordan KR, Iwanaga R, Yamamoto TM, Bailey CA, To F, Jeong AD, Guntupalli SR, Behbakht K, Gibaja V, Arnoult N, Cocozaki A, Chuong EB, Bitler BG. Nguyen LL, et al. Among authors: watson zl. Mol Cancer Ther. 2024 Jun 12:OF1-OF16. doi: 10.1158/1535-7163.MCT-23-0613. Online ahead of print. Mol Cancer Ther. 2024. PMID: 38863225
Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation.
Nguyen LL, Watson ZL, Ortega R, Woodruff ER, Jordan KR, Iwanaga R, Yamamoto TM, Bailey CA, To F, Jeong AD, Guntupalli SR, Behbakht K, Gibaja V, Arnoult N, Cocozaki A, Chuong EB, Bitler BG. Nguyen LL, et al. Among authors: watson zl. Mol Cancer Ther. 2024 May 8:10.1158/1535-7163.MCT-23-0613. doi: 10.1158/1535-7163.MCT-23-0613. Online ahead of print. Mol Cancer Ther. 2024. PMID: 38714351
Novel chromobox 2 inhibitory peptide decreases tumor progression.
Brubaker LW, Backos DS, Nguyen VT, Reigan P, Yamamoto TM, Woodruff ER, Iwanaga R, Wempe MF, Kumar V, Persenaire C, Watson ZL, Bitler BG. Brubaker LW, et al. Among authors: watson zl. Expert Opin Ther Targets. 2023 Apr-May;27(4-5):361-371. doi: 10.1080/14728222.2023.2218614. Epub 2023 May 27. Expert Opin Ther Targets. 2023. PMID: 37243607
Anionic G•U pairs in bacterial ribosomal rRNAs.
Westhof E, Watson ZL, Zirbel CL, Cate JHD. Westhof E, et al. Among authors: watson zl. RNA. 2023 Jul;29(7):1069-1076. doi: 10.1261/rna.079583.123. Epub 2023 Apr 17. RNA. 2023. PMID: 37068913 Free PMC article.
48 results